PRECISION DOSING AND SAFETY OF ENOXAPARIN IN HIGH-RISK PATIENTS WITH COVID-19

被引:0
|
作者
Bonderski, Veronica [1 ]
DeMott, Joshua [2 ]
Whittier, William [2 ]
Panos, Nicholas [2 ]
Rodby, Roger [2 ]
Jain, Shivi [2 ]
Gashti, Casey [2 ]
Gurnani, Payal [2 ]
机构
[1] Univ Chicago Med, Chicago, IL USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
249
引用
收藏
页码:109 / 109
页数:1
相关论文
共 50 条
  • [1] Ramipril in High-Risk Patients With COVID-19
    Amat-Santos, Ignacio J.
    Santos-Martinez, Sandra
    Lopez-Otero, Diego
    Nombela-Franco, Luis
    Gutierrez-Ibanes, Enrique
    Del Valle, Raquel
    Munoz-Garcia, Erika
    Jimenez-Diaz, Victor A.
    Regueiro, Ander
    Gonzalez-Ferreiro, Rocio
    Benito, Tomas
    Sanmartin-Pena, Xoan Carlos
    Catala, Pablo
    Rodriguez-Gabella, Tania
    Delgado-Arana, Jose Raul
    Carrasco-Moraleja, Manuel
    Ibanez, Borja
    San Roman, J. Alberto
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 268 - 276
  • [2] Precision recruitment for high-risk participants in a COVID-19 cohort study
    Mezlini, Aziz M.
    Caddigan, Eamon
    Shapiro, Allison
    Ramirez, Ernesto
    Kondow-McConaghy, Helena M.
    Yang, Justin
    DeMarco, Kerry
    Naraghi-Arani, Pejman
    Foschini, Luca
    [J]. CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33
  • [3] Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19
    Albisinni, Rosina
    Vitrone, Martina
    Ursi, Maria P.
    Spiezia, Serenella
    Salemme, Anna
    Florio, Letizia L.
    Boccia, Filomena
    Iossa, Domenico
    Zampino, Rosa
    Atripaldi, Luigi
    Squillante, Francesco
    Maturo, Nicola
    Fraganza, Fiorentino
    Severino, Sergio
    Punzi, Rodolfo
    Fiorentino, Giuseppe
    [J]. BLOOD TRANSFUSION, 2022, 20 (06) : 495 - 504
  • [4] Early combination therapy of COVID-19 in high-risk patients
    Orth, Hans Martin
    Flasshove, Charlotte
    Berger, Moritz
    Hattenhauer, Sandra Tessa
    Biederbick, Kaja D.
    Mispelbaum, Rebekka
    Klein, Uwe
    Stemler, Jannik
    Fisahn, Matthis
    Doleschall, Anna D.
    Baermann, Ben-Niklas
    Koenigshausen, Eva
    Tselikmann, Olga
    Killer, Alexander
    de Angelis, Clara
    Gliga, Smaranda
    Stegbauer, Johannes
    Spuck, Nikolai
    Silling, Gerda
    Rockstroh, Juergen K.
    Strassburg, Christian P.
    Brossart, Peter
    Panse, Jens P.
    Jensen, Bjoern-Erik Ole
    Luedde, Tom
    Boesecke, Christoph
    Heine, Annkristin
    Cornely, Oliver A.
    Monin, Malte B.
    [J]. INFECTION, 2024, 52 (03) : 877 - 889
  • [5] CKD patients: A high-risk category for severe COVID-19
    Ateya, Areej M.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4086 - 4087
  • [6] Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey
    Pengo, Vittorio
    Del Ross, Teresa
    Tonello, Marta
    Andreoli, Laura
    Tincani, Angela
    Gresele, Paolo
    Silvestri, Elena
    Simioni, Paolo
    Campello, Elena
    Hoxha, Ariela
    Falanga, Anna
    Ghirarduzzi, Angelo
    Denas, Gentian
    [J]. RHEUMATOLOGY, 2022, 61 (SI2) : SI136 - SI142
  • [7] Dengue and Covid-19, a high-risk association
    Buxeraud, Jacques
    [J]. ACTUALITES PHARMACEUTIQUES, 2020, 59 (597): : 7 - 7
  • [8] Rethinking high-risk groups in COVID-19
    Vishnevetsky, Anastasia
    Levy, Michael
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
  • [9] COVID-19 and smoking: a high-risk association
    Oliveira Silva, Andre Luiz
    Moreira, Josino Costa
    Martins, Stella Regina
    [J]. CADERNOS DE SAUDE PUBLICA, 2020, 36 (05):
  • [10] Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19
    Grosso, Dolores
    Wagner, John L.
    O'Connor, Allyson
    Keck, Kaitlyn
    Huang, Yanping
    Wang, Zi-Xuan
    Mehler, Hilary
    Leiby, Benjamin
    Flomenberg, Phyllis
    Gergis, Usama
    Nikbakht, Neda
    Morris, Michael
    Karp, Julie
    Peedin, Alexis
    Flomenberg, Neal
    [J]. BLOOD ADVANCES, 2024, 8 (15) : 4113 - 4124